Skip to main content
. 2024 Mar 11;13(5):1223–1237. doi: 10.1007/s40123-024-00919-w

Fig. 5.

Fig. 5

Outcomes of meibomian gland yielding secretion score increment (ΔMGYSS) in the control (home-based therapy) and treatment (MBE-IPL-MGX) groups according to baseline lower meibomian gland dysfunction grade (L-MGD grade). *P < 0.05, ***P < 0.001